Compare BAP & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAP | CNC |
|---|---|---|
| Founded | 1889 | 1984 |
| Country | Peru | United States |
| Employees | N/A | 61100 |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.5B | 33.1B |
| IPO Year | 1997 | 2001 |
| Metric | BAP | CNC |
|---|---|---|
| Price | $386.74 | $62.13 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 16 |
| Target Price | ★ $309.60 | $46.75 |
| AVG Volume (30 Days) | 288.4K | ★ 3.1M |
| Earning Date | 05-14-2026 | 04-28-2026 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.30 |
| Revenue | N/A | ★ $194,777,000,000.00 |
| Revenue This Year | $23.26 | $8.31 |
| Revenue Next Year | $8.62 | $1.05 |
| P/E Ratio | $12.91 | ★ $11.94 |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $230.45 | $31.63 |
| 52 Week High | $423.17 | $69.63 |
| Indicator | BAP | CNC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | N/A |
| Support Level | N/A | N/A |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.00 | 0.00 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 0.00 |
Credicorp Ltd is a Peruvian financial services company. The company operates in four business lines, including Universal Banking, Insurance and Retirement, Microfinance, and Investment Banking and Asset Management. Its subsidiaries include Banco de Credito del Peru, Prima AFP, Credicorp Capital, and others. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.